Literature DB >> 21572337

Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disorders.

Michael R Hunsaker1, Claudia M Greco, Flora Tassone, Robert F Berman, Rob Willemsen, Randi J Hagerman, Paul J Hagerman.   

Abstract

The FMR1 gene is polymorphic for the length of CGG trinucleotide repeat expansions in the 5' untranslated region. Premutation (55-200 CGG repeats) and full-mutation (>200 CGG repeats) alleles give rise to their respective disorders by different pathogenic mechanisms: RNA gain-of-function toxicity leads to fragile X-associated tremor/ataxia syndrome in the premutation range, and transcriptional silencing and absence of fragile X mental retardation protein (FMRP) lead to fragile X syndrome in the full-mutation range. However, for the latter, incomplete silencing and/or size-mosaicism might result in some contribution to the disease process from residual messenger RNA production. To address this possibility, we examined the brains of 3 cases of fragile X syndrome for the presence of intranuclear inclusions in the hippocampal dentate gyrus. We identified low levels (0.1%-1.3%) of intranuclear inclusions in all 3 cases. Quantitative reverse transcription-polymerase chain reaction for FMR1 messenger RNA and immunofluorescence for FMRP revealed low but detectable levels of both RNA and protein in the 3 cases, consistent with the presence of small numbers of inclusions. The intranuclear inclusions were only present in FMRP-immunoreactive cells. The small numbers of inclusions and very low levels of both FMR1 RNA and protein suggest that the clinical course in these 3 subjects would not have been influenced by contributions from RNA toxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21572337      PMCID: PMC3109086          DOI: 10.1097/NEN.0b013e31821d3194

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  44 in total

1.  Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome.

Authors:  F Tassone; R J Hagerman; D Garcia-Arocena; E W Khandjian; C M Greco; P J Hagerman
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

2.  FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Flora Tassone; Christine Iwahashi; Paul J Hagerman
Journal:  RNA Biol       Date:  2004-07-17       Impact factor: 4.652

3.  FMR1 premutation in females diagnosed with multiple sclerosis.

Authors:  L Zhang; S Coffey; L L Lua; C M Greco; J A Schafer; J Brunberg; M Borodyanskaya; M A Agius; M Apperson; M Leehey; N Tartaglia; F Tassone; P J Hagerman; R J Hagerman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-07       Impact factor: 10.154

4.  Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Authors:  Faraz Farzin; Hazel Perry; David Hessl; Danuta Loesch; Jonathan Cohen; Susan Bacalman; Louise Gane; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

5.  Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients.

Authors:  Chantal Sellier; Frédérique Rau; Yilei Liu; Flora Tassone; Renate K Hukema; Renata Gattoni; Anne Schneider; Stéphane Richard; Rob Willemsen; David J Elliott; Paul J Hagerman; Nicolas Charlet-Berguerand
Journal:  EMBO J       Date:  2010-02-25       Impact factor: 11.598

6.  A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.

Authors:  Stela Filipovic-Sadic; Sachin Sah; Liangjing Chen; Julie Krosting; Edward Sekinger; Wenting Zhang; Paul J Hagerman; Timothy T Stenzel; Andrew G Hadd; Gary J Latham; Flora Tassone
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

7.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

8.  Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis.

Authors:  Claudia M Greco; Flora Tassone; Dolores Garcia-Arocena; Nicole Tartaglia; Sarah M Coffey; Timothy K Vartanian; James A Brunberg; Paul J Hagerman; Randi J Hagerman
Journal:  Arch Neurol       Date:  2008-08

9.  Absence of expression of the FMR-1 gene in fragile X syndrome.

Authors:  M Pieretti; F P Zhang; Y H Fu; S T Warren; B A Oostra; C T Caskey; D L Nelson
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model.

Authors:  Ali Entezam; Rea Biacsi; Bonnie Orrison; Tapas Saha; Gloria E Hoffman; Ed Grabczyk; Robert L Nussbaum; Karen Usdin
Journal:  Gene       Date:  2007-03-16       Impact factor: 3.688

View more
  21 in total

1.  Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers.

Authors:  Deborah Hall; Flora Tassone; Olga Klepitskaya; Maureen Leehey
Journal:  Mov Disord       Date:  2011-12-11       Impact factor: 10.338

2.  FXTAS in an unmethylated mosaic male with fragile X syndrome from Chile.

Authors:  L Santa María; A Pugin; M A Alliende; S Aliaga; B Curotto; T Aravena; H-T Tang; G Mendoza-Morales; R Hagerman; F Tassone
Journal:  Clin Genet       Date:  2013-10-13       Impact factor: 4.438

Review 3.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

4.  Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.

Authors:  C A Hoeffer; E Sanchez; R J Hagerman; Y Mu; D V Nguyen; H Wong; A M Whelan; R S Zukin; E Klann; F Tassone
Journal:  Genes Brain Behav       Date:  2012-02-15       Impact factor: 3.449

Review 5.  Fragile X-associated tremor/ataxia syndrome.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Ann N Y Acad Sci       Date:  2015-01-26       Impact factor: 5.691

6.  CGG trinucleotide repeat length modulates neural plasticity and spatiotemporal processing in a mouse model of the fragile X premutation.

Authors:  Michael R Hunsaker; Kyoungmi Kim; Rob Willemsen; Robert F Berman
Journal:  Hippocampus       Date:  2012-06-18       Impact factor: 3.899

7.  Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone.

Authors:  Zhengyu Cao; Susan Hulsizer; Flora Tassone; Hiu-tung Tang; Randi J Hagerman; Michael A Rogawski; Paul J Hagerman; Isaac N Pessah
Journal:  Hum Mol Genet       Date:  2012-03-30       Impact factor: 6.150

8.  Reduced activity-dependent protein levels in a mouse model of the fragile X premutation.

Authors:  Ramona E von Leden; Lindsey C Curley; Gian D Greenberg; Michael R Hunsaker; Rob Willemsen; Robert F Berman
Journal:  Neurobiol Learn Mem       Date:  2014-01-23       Impact factor: 2.877

9.  CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.

Authors:  Anna Lisa Ludwig; Glenda M Espinal; Dalyir I Pretto; Amanda L Jamal; Gloria Arque; Flora Tassone; Robert F Berman; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

Review 10.  Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Randi Hagerman; Paul Hagerman
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.